 |
 |
Northern Lincolnshire
Formulary |
Formulary Chapter 9: Nutrition and blood - Full Section
|
Notes:
Guideline for the appropriate use of Oral Nutritional Supplements (ONS) for adults in primary care
Oral Nutritional Supplement Prescribing Statement
|
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
09.01 |
Anaemias and some other blood disorders
(0,1)
|
09.01.01 |
Iron-deficiency anaemias
(0,0)
|
09.01.01.01 |
Oral iron
(4,2)
|
|

Iron and folic acid
(1,0)
|
09.01.01.02 |
Parenteral iron
(3,0)
|
09.01.02 |
Drugs used in megaloblastic anaemias
(3,0)
|
09.01.03 |
Drugs used in hypoplastic, haemolytic, and renal anaemias
(1,0)
|
|

Erythropoietin
(3,0)
|
|

Iron overload
(1,0)
|
09.01.04 |
Drugs used in autoimmune thrombocytopenic purpura
(5,0)
|
09.01.05 |
G6PD deficiency
(0,0)
|
09.01.06 |
Drugs used in neutropenia
(2,0)
|
09.01.07 |
Drugs used to mobilise stem cells
(1,0)
|
09.02 |
Fluids and electrolytes
(0,0)
|
09.02.01 |
Oral preparations for fluid and electrolyte imbalance
(0,0)
|
09.02.01.01 |
Oral potassium
(2,0)
|
|

Potassium removal
(2,0)
|
09.02.01.02 |
Oral sodium and water
(1,0)
|
|

Oral rehydration therapy (ORT)
(1,0)
|
09.02.01.03 |
Oral bicarbonate
(1,0)
|
09.02.02 |
Parenteral preparations for fluid and electrolyte imbalance
(0,0)
|
09.02.02.01 |
Electrolytes and water
(0,0)
|
|

Intravenous sodium
(1,0)
|
|

Intravenous glucose
(6,0)
|
|

Intravenous potassium
(6,0)
|
|

Bicarbonate and lactate
(2,0)
|
|

Water
(1,0)
|
09.02.02.02 |
Plasma and plasma substitutes
(0,0)
|
|

Plasma substitutes
(3,0)
|
09.03 |
Intravenous nutrition
(6,0)
|
|

Supplementary preparations
(0,0)
|
09.04 |
Oral nutrition
(0,0)
|
09.04.01 |
Foods for special diets
(1,0)
|
09.04.02 |
Enteral nutrition
(0,0)
|
09.05 |
Minerals
(0,0)
|
09.05.01 |
Calcium and magnesium
(0,0)
|
09.05.01.01 |
Calcium supplements
(3,0)
|
09.05.01.02 |
Hypercalcaemia and hypercalciuria
(1,0)
|
09.05.01.03 |
Magnesium
(0,0)
|
09.05.02 |
Phosphorus
(0,0)
|
09.05.02.01 |
Phosphate supplements
(2,0)
|
09.05.02.02 |
Phosphate-binding agents
(0,0)
|
09.05.03 |
Fluoride
(0,0)
|
09.05.04 |
Zinc
(1,0)
|
09.05.05 |
Selenium
(0,0)
|
09.06 |
Vitamins
(0,0)
|
09.06.01 |
Vitamin A
(0,0)
|
09.06.02 |
Vitamin B group
(2,0)
|
|

Oral vitamin B complex preparations
(1,0)
|
|

Other compounds
(0,0)
|
09.06.03 |
Vitamin C
(1,0)
|
09.06.04 |
Vitamin D
(5,0)
|
09.06.05 |
Vitamin E
(0,0)
|
09.06.06 |
Vitamin K
(4,0)
|
09.06.07 |
Multivitamin preparations
(0,1)
|
|

Vitamin and mineral supplements and adjuncts to synthetic diets
(1,0)
|
09.07 |
Bitters and tonics
(0,0)
|
09.08 |
Metabolic disorders
(0,0)
|
09.08.01 |
Drugs used in metabolic disorders
(0,0)
|
|

Wilsons disease
(0,0)
|
|

Carnitine deficiency
(0,0)
|
|

Fabry's disease
(0,0)
|
|

Gaucher's disease
(0,0)
|
|

Mucopolysaccharidosis I
(0,0)
|
|

Pompe disease
(0,0)
|
|

Nephropathic cystinosis
(0,0)
|
|

Urea cycle disorders
(0,0)
|
09.08.02 |
Acute porphyrias
(0,0)
|
|

Drugs unsafe for use in acute porphyrias
(0,0)
|
|
|
|